Efficacy test of Trichoben vaccine administered to calves at different intervals between vaccination and re-vaccination

被引:2
|
作者
Rybnikar, A. [1 ]
Oborilova, E. [1 ]
Hedbavny, R. [1 ]
机构
[1] Bioveta AS, Ivanovice Na Hane 68323, Czech Republic
关键词
cattle; post-vaccination immunity; challenge; Trichophyton verrucosum;
D O I
10.2754/avb200877020239
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the study was to test a possible extension of the period between vaccination and re-vaccination with the live Trichoben vaccine (Bioveta, a.s., Czech Republic). The calves (n = 61) were vaccinated intramuscularly. The intervals between vaccination and re-vaccination were 3, 5, 7, 10, 14 or 28 days. Another group of calves (n = 16) was vaccinated once with a double dose of the vaccine. The protective immunity against experimental infection with a virulent Trichophyton verrucosum CCM F-650 strain was investigated in animals one month after the last vaccination and compared with a group of non-vaccinated controls (n = 16). Clinical results were evaluated and compared using balanced two-way-ANOVA. The level of post-vaccination immunity in cattle after re-vaccination was sufficient when the intervals were 5, 7, 10, 14 and 28 days. One-time injection of a double prophylactic dose of the vaccine and a 3-day interval between vaccinations reduced the immunity and vaccine efficacy to an unsatisfactory degree. There were significant differences between the groups of calves vaccinated using an interval longer than 5 days, and the group vaccinated once with a double dose, and the group with a 3-day interval between vaccinations. The level of post-vaccination immunity in cattle after re-vaccination at the commonly used interval of 10 - 14 days was identical with the immunity achieved when the interval was reduced to 5 or 7 days or extended up to 28 days. The extension of the interval between vaccinations to 5 - 28 days is recommended for using the Trichoben vaccine in veterinary practice.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 50 条
  • [41] Potency and efficacy of VP20-based vaccine against tilapia lake virus using different prime-boost vaccination regimens in tilapia
    Zeng, Weiwei
    Wang, Yingying
    Chen, Xiaoyu
    Wang, Qing
    Bergmann, Sven M.
    Yang, Ying
    Wang, Yahui
    Li, Bo
    Lv, Yuefeng
    Li, Hua
    Lan, Wensheng
    [J]. AQUACULTURE, 2021, 539
  • [42] Efficacy of intranasal vaccination with a multivalent vaccine containing temperature-sensitive modified-live bovine herpesvirus type 1 for protection of seronegative and seropositive calves against respiratory disease
    Mahan, Suman M.
    Sobecki, Brian
    Johnson, John
    Oien, Nancee L.
    Meinert, Todd R.
    Verhelle, Sarah
    Mattern, Sally J.
    Bowersock, Terry L.
    Leyh, Randy D.
    [J]. JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 2016, 248 (11): : 1280 - 1286
  • [43] IgG-antibodies against ACYW135 meningococcal polysaccharides in C3 deficient and LCCD patients vaccinated with a tetra-valent meningococcal vaccine during a 7-year follow-up and re-vaccination
    Drogari-Apiranthitou, M
    Fijen, CAP
    van de Beek, D
    Hensen, EF
    Dankert, J
    Kuijper, EJ
    [J]. MOLECULAR IMMUNOLOGY, 1999, 36 (4-5) : 293 - 293
  • [44] Efficacy and safety of a booster dose of the meningococcal A, C, W, Y-tetanus toxoid conjugate vaccine administered 10 years after primary vaccination and long-term persistence of tetanus toxoid conjugate or polysaccharide vaccine
    Quiambao, Beatriz
    Peyrani, Paula
    Li, Ping
    Cutler, Mark W.
    Van Der Wielen, Marie
    Perez, John L.
    Webber, Chris
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1272 - 1279
  • [45] COVID-19 Vaccine-related Information Seeking and Scanning: A Test of Mediators between Information Acquisition and Vaccination Intention among Unvaccinated Black Americans
    Zhuang, Jie
    Cobb, Crosby
    [J]. JOURNAL OF HEALTH COMMUNICATION, 2022, 27 (06) : 353 - 361
  • [46] Impact of accounting for correlation between COVID-19 and influenza vaccination in a COVID-19 vaccine effectiveness evaluation using a test-negative design
    Payne, Amanda B.
    Ciesla, Allison Avrich
    Rowley, Elizabeth A. K.
    Weber, Zachary A.
    Reese, Sarah E.
    Ong, Toan C.
    Vazquez-Benitez, Gabriela
    Naleway, Allison L.
    Klein, Nicola P.
    Embi, Peter J.
    Grannis, Shaun J.
    Kharbanda, Anupam B.
    Gaglani, Manjusha
    Tenforde, Mark W.
    Link-Gelles, Ruth
    [J]. VACCINE, 2023, 41 (51) : 7581 - 7586
  • [47] RELATION BETWEEN THE HEMAGGLUTINATION INHIBITION TEST AND THE INDIRECT ELISA IN THE SEROLOGIC MONITORING OF LAYING HENS SUBMITTED TO DIFFERENT SYSTEMS OF VACCINATION AGAINST NEWCASTLE-DISEASE
    RICHTZENHAIN, LJ
    PAULILLO, AC
    PINTO, AA
    KRONKA, SN
    [J]. REVISTA DE MICROBIOLOGIA, 1993, 24 (03): : 187 - 191
  • [48] OPTIMUM VACCINATION DOSES OF MENINGOCOCCAL CHEMICAL POLYVALENT ABC-VACCINE FOR THE IMMUNIZATION OF CHILDREN OF DIFFERENT AGE-GROUPS .2. IMMUNOLOGICAL EFFECTIVENESS OF THE PREPARATION UNDER TEST
    GANZENKO, VP
    SUMAROKOV, AA
    NIKONOVA, VA
    FILIPPOV, YV
    NOVO, MV
    DIAZ, R
    RODRIGUEZ, JA
    FERNANDEZ, F
    [J]. ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1983, (04): : 23 - 26
  • [49] Binding and neutralizing antibody levels and vaccine efficacy/effectiveness compared between heterologous and homologous primary series COVID-19 vaccination: A systematic review and meta-analysis
    Angkasekwinai, Nasikarn
    Prawjaeng, Juthamas
    Leelahavarong, Pattara
    Khuntha, Sarayuth
    Pheerapanyawaranun, Chatkamol
    Chitpim, Natthakan
    Srinonprasert, Varalak
    Chokephaibulkit, Kulkanya
    [J]. ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2022, 40 (04): : 321 - 336